MACROLIDE TOTAL SYNTHESIS
大环内酯全合成
基本信息
- 批准号:3283922
- 负责人:
- 金额:$ 22.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-01 至 1991-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The overall objective of this research program is the development
of efficient synthetic procedures for construction of structurally
complex macrolide natural products. The specific targets include
latrunculin A, acutiphycin, 20,21-didehydroacutiphycin,
aplysiatoxin, debromoaplysiatoxin and oscillatoxin A.
The latrunculins (A and B) represent a new class of highly potent
macrolides that specifically bind to cytoskeletal proteins and
thereby disrupt microfilament organization in cultured cells
without effecting the microtubular system. The mode of action,
while still unknown, most closely resembles the activity displayed
by the cytochalasins, the only other class of drugs known to bind
to actin filaments and to specifically disrupt the
mocrofilamentous structures. The latrunculins, however are 10 to
100 times more active than the cytochalasins.
Acutiphycin and 20,21-didehydroacutiphycin are macrolides,
isolated from the lipophilic extract of the freshwater algae,
Oscillatoria acutissima.3 They display cytotoxicity against KB
and NIH/3T3 cells as well as significant antineoplastic activity in
vivo against murine Lewis lung carcinoma.3
Aplysiatoxin, debromoaplysiatoxin, and oscillatoxin A, also
isolated from algae, are potent tumor promoters possessing
complex macrolide structures. Each of the above macrolides
represents an extremely important target from the point of view
of synthetic chemistry and biological potency (i.e., antitumor or
tumor promoter activity).
In addition to the above quite specific synthetic targets, a more
general underlying and long range aim of this research program is
the development of a better understanding of the molecular
architecture responsible for the biological properties of these and
related macrolides. Thus, as we develop our method of procedure
for each of the above targets, we will also introduce various
model systems which will be amenable to construction and
subsequent screening, such that in the end we will be able to
dissect out the critical structural feature of features responsible
for the observed biological activities. Once such features are
identified, the design of new and possible more effective agents
should be feasible.
本研究计划的总体目标是发展
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amos B Smith其他文献
Amos B Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amos B Smith', 18)}}的其他基金
Dictyostatin and related prodrugs as candidates for tauopathy treatment
Dictyostatin 和相关前药作为 tau 蛋白病治疗的候选药物
- 批准号:
8821175 - 财政年份:2014
- 资助金额:
$ 22.28万 - 项目类别:
Pilot-Scale Libraries for High-throughput Screening
用于高通量筛选的中试规模文库
- 批准号:
7291136 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别:
Pilot-Scale Libraries for High-throughput Screening
用于高通量筛选的中试规模文库
- 批准号:
7684229 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别: